186 related articles for article (PubMed ID: 27639904)
1. Feasibility and Safety of Robotic Peripheral Vascular Interventions: Results of the RAPID Trial.
Mahmud E; Schmid F; Kalmar P; Deutschmann H; Hafner F; Rief P; Brodmann M
JACC Cardiovasc Interv; 2016 Oct; 9(19):2058-2064. PubMed ID: 27639904
[TBL] [Abstract][Full Text] [Related]
2. Robotic Peripheral Vascular Intervention With Drug-Coated Balloons is Feasible and Reduces Operator Radiation Exposure: Results of the Robotic-Assisted Peripheral Intervention for Peripheral Artery Disease (RAPID) Study II.
Mahmud E; Schmid F; Kalmar P; Deutschmann H; Hafner F; Rief P; Cain C; Ang L; Brodmann M
J Invasive Cardiol; 2020 Oct; 32(10):380-384. PubMed ID: 32999092
[TBL] [Abstract][Full Text] [Related]
3. DETOUR2 trial outcomes demonstrate clinical utility of percutaneous transmural bypass for the treatment of long segment, complex femoropopliteal disease.
Lyden SP; Soukas PA; De A; Tedder B; Bowman J; Mustapha JA; Armstrong EJ;
J Vasc Surg; 2024 Jun; 79(6):1420-1427.e2. PubMed ID: 38367850
[TBL] [Abstract][Full Text] [Related]
4. 1-Year Results of a Multicenter Randomized Controlled Trial Comparing Heparin-Bonded Endoluminal to Femoropopliteal Bypass.
Reijnen MMPJ; van Walraven LA; Fritschy WM; Lensvelt MMA; Zeebregts CJ; Lemson MS; Wikkeling ORM; Smeets L; Holewijn S
JACC Cardiovasc Interv; 2017 Nov; 10(22):2320-2331. PubMed ID: 29169500
[TBL] [Abstract][Full Text] [Related]
5. Heparin-bonded stent-graft for the treatment of TASC II C and D femoropopliteal lesions: the Viabahn-25 cm trial.
Zeller T; Peeters P; Bosiers M; Lammer J; Brechtel K; Scheinert D; Rastan A; Noory E; Beschorner U
J Endovasc Ther; 2014 Dec; 21(6):765-74. PubMed ID: 25453876
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of the Japanese multicenter Viabahn trial of endovascular stent grafting for superficial femoral artery lesions.
Ohki T; Kichikawa K; Yokoi H; Uematsu M; Yamaoka T; Maeda K; Kanaoka Y
J Vasc Surg; 2017 Jul; 66(1):130-142.e1. PubMed ID: 28400218
[TBL] [Abstract][Full Text] [Related]
7. Jetstream Atherectomy System treatment of femoropopliteal arteries: Results of the post-market JET Registry.
Gray WA; Garcia LA; Amin A; Shammas NW;
Cardiovasc Revasc Med; 2018 Jul; 19(5 Pt A):506-511. PubMed ID: 29331436
[TBL] [Abstract][Full Text] [Related]
8. Treating Post-Angioplasty Dissection in the Femoropopliteal Arteries Using the Tack Endovascular System: 12-Month Results From the TOBA II Study.
Gray WA; Cardenas JA; Brodmann M; Werner M; Bernardo NI; George JC; Lansky A
JACC Cardiovasc Interv; 2019 Dec; 12(23):2375-2384. PubMed ID: 31806218
[TBL] [Abstract][Full Text] [Related]
9. Lower Extremity Revascularization Using Optical Coherence Tomography-Guided Directional Atherectomy: Final Results of the EValuatIon of the PantheriS OptIcal COherence Tomography ImagiNg Atherectomy System for Use in the Peripheral Vasculature (VISION) Study.
Schwindt AG; Bennett JG; Crowder WH; Dohad S; Janzer SF; George JC; Tedder B; Davis TP; Cawich IM; Gammon RS; Muck PE; Pigott JP; Dishmon DA; Lopez LA; Golzar JA; Chamberlin JR; Moulton MJ; Zakir RM; Kaki AK; Fishbein GJ; McDaniel HB; Hezi-Yamit A; Simpson JB; Desai A
J Endovasc Ther; 2017 Jun; 24(3):355-366. PubMed ID: 28393673
[TBL] [Abstract][Full Text] [Related]
10. The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protégé EverfLex NitInol STent SYstem II (DURABILITY II).
Matsumura JS; Yamanouchi D; Goldstein JA; Pollock CW; Bosiers M; Schultz GA; Scheinert D; Rocha-Singh KJ
J Vasc Surg; 2013 Jul; 58(1):73-83.e1. PubMed ID: 23642924
[TBL] [Abstract][Full Text] [Related]
11. PRELUDE Prospective Study of the Serranator Device in the Treatment of Atherosclerotic Lesions in the Superficial Femoral and Popliteal Arteries.
Holden A; Hill A; Walker A; Buckley B; Merrilees S; Nowakowski P; Krzanowski M; Brodmann M
J Endovasc Ther; 2019 Feb; 26(1):18-25. PubMed ID: 30580697
[TBL] [Abstract][Full Text] [Related]
12. Long-term clinical and quality of life outcomes after stenting of femoropopliteal artery stenosis: 3-year results from the STROLL study.
Bunte MC; Cohen DJ; Jaff MR; Gray WA; Magnuson EA; Li H; Feiring A; Cioppi M; Hibbard R; Gray B; Khatib Y; Jessup D; Patarca R; Du J; Stoll HP; Massaro J; Safley DM;
Catheter Cardiovasc Interv; 2018 Jul; 92(1):106-114. PubMed ID: 29521013
[TBL] [Abstract][Full Text] [Related]
13. JetStream Rotational and Aspiration Atherectomy in Treating In-Stent Restenosis of the Femoropopliteal Arteries: Results of the JETSTREAM-ISR Feasibility Study.
Shammas NW; Shammas GA; Banerjee S; Popma JJ; Mohammad A; Jerin M
J Endovasc Ther; 2016 Apr; 23(2):339-46. PubMed ID: 26921281
[TBL] [Abstract][Full Text] [Related]
14. 1-Year Results of Paclitaxel-Coated Balloons for Long Femoropopliteal Artery Disease: Evidence From the SFA-Long Study.
Micari A; Vadalà G; Castriota F; Liso A; Grattoni C; Russo P; Marchese A; Pantaleo P; Roscitano G; Cesana BM; Cremonesi A
JACC Cardiovasc Interv; 2016 May; 9(9):950-6. PubMed ID: 27151609
[TBL] [Abstract][Full Text] [Related]
15. Safety and Feasibility of a Novel, Second-Generation Robotic-Assisted System for Percutaneous Coronary Intervention: First-in-Human Report.
Smitson CC; Ang L; Pourdjabbar A; Reeves R; Patel M; Mahmud E
J Invasive Cardiol; 2018 Apr; 30(4):152-156. PubMed ID: 29335386
[TBL] [Abstract][Full Text] [Related]
16. The use of endografts to create an endoluminal femoropopliteal bypass after failed above-knee femoropopliteal open bypass surgery.
Lensvelt MM; Wikkeling OR; Van Oostayen JA; Roukema JG; Zeebregts CJ; Reijnen MM
Vasc Endovascular Surg; 2012 May; 46(4):338-41. PubMed ID: 22504512
[TBL] [Abstract][Full Text] [Related]
17. Adventitial Drug Delivery of Dexamethasone to Improve Primary Patency in the Treatment of Superficial Femoral and Popliteal Artery Disease: 12-Month Results From the DANCE Clinical Trial.
Razavi MK; Donohoe D; D'Agostino RB; Jaff MR; Adams G;
JACC Cardiovasc Interv; 2018 May; 11(10):921-931. PubMed ID: 29730377
[TBL] [Abstract][Full Text] [Related]
18. Twelve-Month Results From the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Treatment of Obstructive Femoropopliteal Disease.
Müller-Hülsbeck S; Keirse K; Zeller T; Schroë H; Diaz-Cartelle J
J Endovasc Ther; 2016 Oct; 23(5):701-7. PubMed ID: 27193308
[TBL] [Abstract][Full Text] [Related]
19. Safety and efficacy of antiplatelet/anticoagulation regimens after Viabahn stent graft treatment for femoropopliteal occlusive disease.
Ullery BW; Tran K; Itoga N; Casey K; Dalman RL; Lee JT
J Vasc Surg; 2015 Jun; 61(6):1479-88. PubMed ID: 25704407
[TBL] [Abstract][Full Text] [Related]
20. Treatment of the femoropopliteal artery with the bioresorbable REMEDY stent.
Bontinck J; Goverde P; Schroë H; Hendriks J; Maene L; Vermassen F
J Vasc Surg; 2016 Nov; 64(5):1311-1319. PubMed ID: 27462002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
